Michael Castagna
Patrimonio netto: 10 M $ in data 30/06/2026
Patrimonio netto: 10 M $ in data 30/06/2026
Michael E.
Castagna is Chief Executive Officer & Director at MannKind Corp.
since 2017, President, Chief Executive Officer & Director at scPharmaceuticals, Inc. starting in 2025, and Director at Pet Partners.
Former roles include Executive Director-Immunology Franchise at Bristol Myers Squibb Co. from 2010 to 2012, Director at Pharmasset, Inc. from 2005 to 2006, Vice President-Global Commercial at Amgen, Inc. from 2012 to 2016, Vice President & Head-Biopharmaceuticals at Sandoz, Inc. from 2009 to 2010, and VP & Head-North America Biopharmaceuticals at Novartis AG.
Education includes a doctorate from Massachusetts College of Pharmacy & Health Science in 2014, an MBA from The Wharton School of the University of Pennsylvania in 2005, and an undergraduate degree from Philadelphia College of Pharmacy in 2000.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
MANNKIND CORPORATION 0,79% | 11/05/2026 | 2.442.310 ( 0,79% ) | 10 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MANNKIND CORPORATION | Amministratore Delegato | 25/05/2017 |
| SCPHARMACEUTICALS INC. | Amministratore Delegato | 07/10/2025 |
Pet Partners
Pet Partners Agricultural Commodities/MillingProcess Industries Provides pet therapy services | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 14/03/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/11/2012 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Corporate Officer/Principal | 01/11/2010 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Direttore/Membro del Consiglio | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MannKind Corp.
MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Philadelphia College of Pharmacy
Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pet Partners
Pet Partners Agricultural Commodities/MillingProcess Industries Provides pet therapy services | Process Industries |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale